Evidence map›Paper›PMID 32021929›Full record

ArticleHeliyon2020

A novel synthesis of new antibacterial nanostructures based on Zn-MOF compound: design, characterization and a high performance application.

Fatemeh Akbarzadeh, Mehdi Motaghi, Narendra Pal Singh Chauhan, Ghasem Sargazi

RetractedAbstract readRetracted Publication
In one paragraph

Article in Heliyon, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. MOFs and MOF-Derived Materials for Antibacterial Application.Journal of functional biomaterials · 2022
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Fatemeh AkbarzadehDepartment of Microbiology, Kerman Branch, Islamic Azad University, Kerman, Iran.
Mehdi MotaghiDepartment of Microbiology, Kerman Branch, Islamic Azad University, Kerman, Iran.
Narendra Pal Singh ChauhanDepartment of Chemistry, Faculty of Science, Bhupal Nobles'University, Udaipur, Rajasthan, India.
Ghasem SargaziEnvironment and Nanochemistry Department, Research Institute of Environmental Science, International Center for Science, High Technology & Environmental Science, Kerman, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, the novel zinc metal-organic frameworks (MOF) nanostructure has been employed, which was developed using an affordable, environmental friendly, efficient and fast method of ultrasound-assisted reverse micelle (UARM). These nanostructures were identified with various techniques such as FT-IR, XRD, BET, SEM, TG-DSC, TEM and EDS. It was found that the Zn-MOF samples have favorable physicochemical properties. The impact of experimental parameters of the UARM method is effective on the resulting properties, such as high surface area of the products that increases the interactions between the Zn-MOF nanostructure and bacteria.Their antibacterial activities were investigated using diffusion methods in agar and also with dilutions of Zn-MOF samples. Antibiotics (tetracycline and ampicillin) and their anti-biofilm effects were evaluated using microplate method. Obtained results revealed that the Zn-MOF nanostructures have high antibacterial properties which, could be due to the nature of the applied Zn-MOF as well as the optimization process. The Zn- MOF nanostructures could be a novel antibacterial material as biocatalyst processes.

Indexed as

BiofilmBiotechnologyGrowth inhibitory concentrationMicrobiologyUARM methodZn-MOF

Identifiers

PMID32021929
PMCPMC6994313

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.